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Mitochondrial membrane potentialThe mitochondrial F1F0-ATP synthase or ATPase is a key enzyme for aerobic energy production in eukaryotic
cells. Mutations in ATPase structural and assembly genes are the primary cause of severe human
encephalomyopathies, frequently associated with a pleiotropic decrease in cytochrome c oxidase (COX)
activity. We have studied the structural and functional constraints underlying the COX defect using Sac-
charomyces cerevisiae genetic and pharmacological models of ATPase deﬁciency. In both yeast Δatp10 and
oligomycin-treated wild type cells, COX assembly is selectively impaired in the absence of functional ATPase.
The COX biogenesis defect does not involve a primary alteration in the expression of the COX subunits as
previously suggested but in their maturation and/or assembly. Expression of COX subunit 1, however, is
translationally regulated as in most bona ﬁde COX assembly mutants. Additionally, the COX defect in
oligomycin-inhibited ATPase-deﬁcient yeast cells, but not in atp10 cells could be partially prevented by
partially dissipating the mitochondrial membrane potential using the uncoupler CCCP. Similar results were
obtained with oligomycin-treated and ATP12-deﬁcient human ﬁbroblasts respectively. Our ﬁndings imply
that fully assembled ATPase and its proton pumping function are both required for COX biogenesis in yeast
and mammalian cells through a mechanism independent of Cox1p synthesis.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Mutations in nuclear and mitochondrial genes affecting the F1F0-
ATP synthase or complex V function result in rare devastating
encephalomyopathies [1]. Mitochondrial F1F0-ATPase is a multimeric
complex formed by two functionally and physically coupled portions
of dual genetic origin. The inner membrane-embedded F0 sector
contains mitochondrial DNA (mtDNA) encoded subunits and the
hydrophilic F1 sector is attached to it from the matrix side [2]. The F0
sector forms a ring-like structure that rotates in themembrane bilayer
and drives proton translocation across the inner membrane which is
coupled to the synthesis of ATP from ADP and inorganic phosphate.
This catalytic capacity is located in the F1 sector. Protons ﬂow through
the F0 in favor of the proton gradient generated across the
mitochondrial inner membrane by the mitochondrial respiratory
chain (MRC) enzymes. The MRC is formed by four enzymatic
complexes embedded in the inner membrane and two mobile
electron carriers, coenzyme Q and cytochrome c (cyt c). Electrons
donated from reducing equivalents to the MRC complexes ﬂow downd Biochemistry and Molecular
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acceptor. The transfer of electrons to oxygen is catalyzed by
cytochrome c oxidase (COX) or complex IV, another multimeric
enzyme of dual genetic origin, containing copper and heme A as metal
prosthetic groups. Complexes I (in higher eukaryotes), III and IV
couple electron transfer with proton extrusion from the matrix to the
mitochondrial inner membrane space, thus generating the driving
force for ATP synthesis. It is now generally accepted that complexes I,
III and IV interact physically to form supercomplexes with different
stoichiometries, some of which contain coenzyme Q and cyt c and
constitute real respirasomes [3]. The assembly and stability of some of
the individual enzymes depend on their interaction with the others.
For example, complex I assembly requires the presence of complexes
III and IV [4,5] and complex IV assembly requires the structural
presence of cyt c in yeast and mammals [6,7]. The ATPase complex is
known to form oligomers that play a role in the maintenance of the
mitochondrial inner membrane cristae structure but it has not been
shown to physically interact with MRC enzymes.
As a consequence of the structural supra-organization of the MRC
and the single complex biogenesis dependence on other MRC
components, alterations in one protein-coding gene can result in
combined enzyme complex defects. For example, some mutations in
the mtDNA-encoded cytochrome b, a subunit of MRC complex III,
produces a combined complex I+III deﬁciency in human patients
suffering from encephalomyopathies [8]. Based on the absence of
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deﬁciencies should not be expected in cases of patients with
mutations affecting ATPase structure and function. However, in
several reported cases, the ATPase deﬁciency was associated with a
pleiotropic decrease in COX activity speciﬁcally or as the major part of
a more general MRC alteration. Maternally transmitted ATPase
disorders, NARP (neuropathy, ataxia and retinitis pigmentosa) and
MILS (maternally inherited Leigh's syndrome), are caused by muta-
tions in the mitochondrial ATPase structural genes ATP6 [9] and more
rarely ATP8 [10]. Biochemical analysis in samples from MILS patients
carrying mutations in ATP6, which affect the function but at least not
extensively the assembly of the ATPase, showed a signiﬁcant COX
activity decline in skeletal muscle [11]. Analysis of an ATP6 NARP
mutation in cybrid cell lines also showed a MRC deﬁciency with a
predominant COX defect and increased ROS production [12]. ATPase
disorders of nuclear genetic origin manifest a very severe outcome as
well [13]. A case has been associated with a homozygous mutation in
ATP12, the human homologue of a nuclear encoded assembly gene
previously described in yeast [14]. Similar to yeast atp12mutant cells
which are COX deﬁcient [14], the patient presented a pleiotropic COX
defect in skeletal muscle [15].
Mutations in several ATPase nuclear structural genes in the yeast
Saccharomyces cerevisiae, including ATP1, ATP2, ATP4, ATP7, ATP8 and
ATP9 have been reported to affect COX biogenesis [16–20]. However,
some ATPase mutations reduce mtDNA stability and produce a large
amount of ρ−/ρ0 cells (cells with partial or complete absence of
mtDNA)[21] making it difﬁcult to assess to which degree and how
COX assembly is speciﬁcally affected in these mutants. With the
exception of some ATPase mutants that are petite obligate [22], the
problem has been solved by introducing a nutritional selection
marker in the mitochondrial DNA [23]. Analysis of a null atp6mutant
in this context showed a selective decrease in COX accumulation to
residual amounts barely detectable [24]. Furthermore, yeast models
of NARP and MILS syndrome, carrying the ATP6 yeast equivalent
mutations T8993G and T8993C, respectively, show a selective and
dramatic decrease in COX activity and content [24,25]. At present, the
molecular mechanism involved in this pleiotropic effect remains
unknown but its relevance is underscored by the fact that it is
conserved from yeast to human.
Several hypotheses have been proposed to explain the ATPase
function on COX assembly invoking functional and structural
constraints. ATPase lesions blocking proton pumping across the
inner membrane affect both ATP production and the mitochondrial
membrane potential (Δψm). The maintenance of a high Δψm could be
deleterious for the cells by limiting the glycolytic ATP import necessary
for the survival of respiratory-deﬁcient mutants. It has been proposed
that the poor COX assembly allows ATPase mutant cells to import
glycolytic ATP intomitochondria by decreasingΔψm [20,24] or to avoid
the accumulation of reduced intermediary components of the
respiratory chain [20]. This hypothesis is supported by the fact that
COX biogenesis is not altered in uncoupled ATPase mutants where
Δψmmaintenance is severely compromised by proton leakage through
F0 [26,27] while it is altered in oligomycin-treatedwild-type cells [20].
However, COXwas also found decreased in yeast atp6pointmutants in
which the F0 proton pumping capacity was not affected [25]. In these
atp6mutants, the stoichiometry of the supercomplexes formedbyCOX
and the bc1 complex (complex III) was found additionally altered [25].
A similar observation was made in mutants of the dimer-speciﬁc
ATPase subunits e and g, which destabilize dimeric and oligomeric
ATPase, suggesting an involvement of the ATPase in the maintenance
of the correct COX-bc1 super-complexes organization [28], although
there are conﬂicting reports about whether Δψm, COX assembly and
function are affected in these mutants [28,29].
COX biogenesis is a complex process requiring more than 30
ancillary factors to facilitate the expression, maturation by addition of
prosthetic groups and assembly of three mtDNA encoded subunits (1to 3) forming the COX catalytic core and 8 (yeast) or 10 (humans)
nuclear-encoded subunits forming a protective scaffold around the
core [30]. Which are the COX assembly step/s speciﬁcally affected in
ATPase-deﬁcient cells? In yeast, the COX biogenesis defect could
result from the decreased rate of Cox1p synthesis observed in several
ATPase mutants [18,19,24]. However, in other cases, Cox1p synthesis
was found normal and the COX defect was suggested to be caused by a
block in heme A biosynthesis or insertion into Cox1p [17].
To gain insight into the function of the F1F0-ATPase on COX
biogenesis, we have used genetic and pharmacological yeast and
human cells models of ATPase deﬁciencies. Our results show that in S.
cerevisiae, ATPase lesions do not affect Cox1p translation directly
although it is downregulated as a consequence of the COX assembly
defect. Additionally, our results demonstrate that COX biogenesis in
yeast and mammalian cells requires both a functional ATPase proton
pump and a structurally integral and fully assembled F1–F0 ATPase.
2. Materials and methods
2.1. Yeast strains and media
The S. cerevisiae strains used were all in the W303 background and
included the wild type W303-1A (MATa ade2-1 his3-1,15 leu2-3,112
trp1-1 ura3-1) and the previously reported mutants Δatp10 [31],
Δcox14 and Δcox14Δcox15 [32] and Δcox15 [33]. Mutant Δatp10 cells
were transformed with an integrative plasmid containing the mss51
suppressor mss51T167R as reported [32]. The Δatp10Δcox14 double
mutant was obtained from crosses of the respective single mutants.
The compositions of the growthmedia have been described elsewhere
[34]. The following media were used routinely to grow yeast: YPD (2%
glucose, 1% yeast extract, 2% peptone), YPGal (2% galactose, 1% yeast
extract, 2% peptone), YPEG (2% ethanol, 3% glycerol, 1% yeast extract,
2% peptone), WO-EG (2% ethanol, 3% glycerol, 0.67% yeast nitrogen
base), WO-Gal (2% galactose, 0.67% yeast nitrogen base).
2.2. Culture supplementation with oligomycin and CCCP
Cells were grown to early stationary phase in galactose containing
media either complete (for mitochondrial preparation assays) or
synthetic plus prototrophic requirements. Subsequently, cells were
inoculated to OD600 equal to 1 in fresh media supplemented or not
with 2 μM oligomycin, 5 μM CCCP or both drugs simultaneously. Cells
were incubated for up to 16 h at 30 °C with constant shaking.
2.3. Mitochondrial respiratory chain enzyme spectrophotometric
measurements
Mitochondria were prepared from strains grown in media
containing 2% galactose, according to the method of Faye et al. [35]
except that zymolyase 20T (ICN Biochemicals Inc., Aurora, OH)
instead of Glusulase was used for the conversion of cells to
spheroplasts. Mitochondria prepared from the different strains were
used for spectrophotometric assays carried out at 24 °C. KCN-sensitive
cytochrome c oxidase (COX) activity was assayed with 50 μg of
mitochondria which were permeabilized with potassium deoxycho-
late as described [36], by following the oxidation of 50 μM reduced
cytochrome c at 550 nm in a medium containing 20 mM KH2PO4 (pH
7.4). The addition of 0. 3 mMKCN inhibited the reaction. Antimycin A-
sensitive NADH cytochrome c reductase (NCCR) activity was assayed
in 25 μg of mitochondria permeabilized with potassium deoxycholate
as described [36] by measuring, at 550 nm, the reduction of oxidized
50 μM cytochrome c using 0.4 mM NADH as the electron donor in a
medium containing 20 mM KH2PO4 (pH 7.4) and 2 mM EDTA. The
addition of 0.4 μM antimycin A inhibited the reaction. ATPase activity
was assayed by measuring release of inorganic phosphate [37] from
ATP at 37 °C in the presence and absence of oligomycin.
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Mitochondrial gene products were labeled with 35S-methionine
(7 mCi/mmol, Amersham, Piscataway, NJ) in whole cells at 30 °C in
the presence of cycloheximide [36]. Equivalent amounts of total
cellular or mitochondrial proteins were separated by SDS-PAGE on a
17.5% polyacrylamide gel, transferred to a nitrocellulose membrane,
and exposed to Kodak X-OMAT X-ray ﬁlm.
2.5. Measurement of Ψm
Ψmwas estimated using rhodamine 123 (Rh123), a cell-permeant,
cationic, ﬂuorescent dye that is readily sequestered by viable
mitochondria. A 30 min incubation of 106 yeast cells per ml in
50 μM Rh123 at 24 °C allowed sufﬁcient uptake of Rh123 into the
matrix to self-quench as reported [38]. The cells were then washed 2×
in water. Flow cytometry analysis was performed on a Becton
Dickinson (BD) FACSCalibur ﬂow cytometric analyzer. Excitation
was at 488 nm; emission was detected using a 40 nm bandpass ﬁlter
centered at 535 nm (Chroma, Rockingham, VT, USA). Depolarization
of Ψm caused Rh123 to leak out of mitochondria into the cytosol
where Rh123 became unquenched, producing an increase in
ﬂuorescence (reviewed by [39]). This interpretation is supported by
the data of Fig. 4A, which show an increase in Rh123 ﬂuorescence
following application of the ionophore carbonyl cyanide m-chloro
phenyl hydrazone (CCCP), and a decrease following application of
oligomycin, expected to hyperpolarize mitochondria.
2.6. Human cell lines, culture conditions, enzyme assays and
immunodetections
A previously reported primary ﬁbroblast line from amitochondrial
ATPase-deﬁcient disease patient was obtained from Dr. Sara Seneca
(University Hospital VUB, Brussels, Belgium) [15]. The patient carried
a homozygous mutation in ATP12, an ATPase assembly gene. Human
neonatal ﬁbroblasts (CCD-10645k) were obtained from ATCC (Man-
assas, VA). The ﬁbroblast cell lines were immortalized by transducing
human papilloma virus (HPV) 16 E6/E7 oncogenes. Cells were
cultured in high glucose Dulbecco's modiﬁed Eagle's medium
supplemented with 10% fetal bovine serum and 100 μg/ml sodium
pyruvate and 0.25 mg/ml uridine.
mtDNA content was estimated by Southern blot analysis as
described [40] . Brieﬂy, 6 mg of total DNA was digested with PvuII,
which linearizes human mtDNA by cleaving at nt 2653 and produces
an 12 kb fragment of the human rDNA repeat unit containing the 18S
rRNA gene. Digested samples were resolved on 0.8% agarose gels and
transferred onto nitrocellulose membranes. mtDNA was detected
using [α-32P]-dCTP-labeled, random primed probes generated against
a 16.1 kb human mtDNA PCR product. Signals were normalized
against the 18S rDNA signal detected using similar probes generated
against a 0.6 kb PCR fragment of the human rDNA repeat unit
encompassing the 18S rDNA gene.
To measure COX activity in cells homogenates, cells were collected
by trypsinization and submitted to three freezing–thawing cycles.
COX and NCCR activities were measured in the presence of lauryl
maltoside as described [41].
Cell homogenates were also used to estimate COX content by
western blot analyses using an antibody against human COX1
(Molecular Probes). An antibody against β-tubulin (Molecular
Probes) was used as loading control.
2.7. Miscellaneous procedures
Standard procedures were used for transformation and recovery of
plasmid DNA from Escherichia coli [42]. Yeast cells were transformed
by the method of Schiestl and Gietz [43]. The one-step gene insertionmethod [44] was used to integrate linear plasmids at the URA3 or
LEU2 locus of yeast nuclear DNA. Protein concentration was measured
with the Folin phenol reagent [45]. Proteins were separated by SDS-
PAGE in the buffer system of Laemmli [46], and western blots were
treated with antibodies against the appropriate proteins followed by a
second reaction with anti-mouse or anti-rabbit IgG conjugated to
horseradish peroxidase (Sigma, St. Louis, MO). The SuperSignal
chemiluminescent substrate kit (Pierce, Rockford, IL) was used for
the ﬁnal detection.
2.8. Statistical analyses
All experiments (enzymatic assays, western blot quantiﬁcations)
were done at least in triplicate. For the enzymatic assays, data are
presented as means±SD of absolute values. The values obtained for
wild type and mutant strains were compared by Student t-test.
Pb0.05 was considered signiﬁcant. For quantiﬁcation of western blot
signals, the images were digitalized and densitometry performed
using the histogram function of the Adobe Photoshop program. The
values measured in three independent assays did not differ by more
than 5%.
3. Results
3.1. The absence of a fully assembled mitochondrial ATPase induces a
pleiotropic COX deﬁciency in yeast Δatp10 mutant cells
To investigate the molecular requirement of an intact and
functional ATPase for COX biogenesis we have used a yeast strain
in which Atp6p assembly into the ATPase complex is prevented by a
nuclear mutation in its speciﬁc chaperone Atp10p [31]. This choice
is justiﬁed based on the high mtDNA stability in this mutant
(Fig. 1A). For all the experiments reported, we used freshly puriﬁed
mtDNA-containing (ρ+) colonies and the results were normalized
by the percentage of ρ+ cells in the culture used for each
experiment (mitochondrial preparation, protein synthesis analyses,
etc), which was always between 85% and 95%. As previously
reported, the oligomycin sensitive ATPase activity in Δatp10 cells
was less than 5% of wild type ([31] and Fig. 1B). Similar to other
mutants in structural and assembly ATPase genes [14,16–19,47], we
have observed that the lack of Atp10p results in a selective decrease
in COX activity to a residual amount of approximately 10% of wild-
type (Fig. 1C) with a very mild effect on the upstream portion of the
MRC measured by the NADH cytochrome c reductase (NCCR) assay
(Fig. 1D). The pleiotropic effect on COX was not reciprocal since a
mutation in cox15, a gene essential for heme A biosynthesis and
hence COX biogenesis [33], does not affect ATPase function
(Fig. 1B). In agreement with the COX activity decline and similar
to atp6 mutants [24], atp10 mutant cells present a dramatic
reduction of the steady state level of Cox1p and to a signiﬁcantly
lesser extent Cox2p and Cox3p (Fig. 1E). The signiﬁcant stability of
unassembled Cox2p and Cox3p in atp10 mutant cells is intriguing.
This result differs from most bona ﬁde COX mutants, including
Δcox15, in which most unassembled highly hydrophobic core
subunits are proteolytically degraded and do not accumulate at
the steady-state level (Fig. 1E).
3.2. The ATPase proton pump inhibitor oligomycin induces a pleiotropic
speciﬁc effect on COX accumulation and function in yeast cells
To test whether or not the COX assembly defect in ATPase
mutants exclusively results from structural ATPase defects, we have
explored an ATPase-deﬁciency yeast pharmacological model con-
sisting of treatment of a wild type strain with oligomycin.
Oligomycin acts by stalling proton translocation through the ATPase
F0 channel thus blocking ATP synthesis and producing inner
Fig. 1. The absence of a functional mitochondrial ATPase induces a pleiotropic COX deﬁciency in yeast Δatp10mutant cells. (A) mtDNA stability in wild type and cells carrying a null
allele of either atp10 or cox15 was estimated by counting the percentage of cells that retained their mtDNA (ρ+ cells) after 20 generations. (B) ATPase activity measured as ATP
hydrolysis in isolated mitochondria in wild type (WT), Δatp10 and Δcox15mutant cells in the presence and absence of 2 μMoligomycin. (C) Cytochrome c oxidase activity measured
spectrophotometrically in isolated mitochondria following the oxidation of reduced cytochrome c. (D) NADH cytochrome c reductase (NCCR) activity in wild type and Δatp10 cells
measured spectrophotometrically in isolated mitochondria following the reduction of oxidized cytochrome c in the presence of NADH. (E) Western blot analyses of the steady state
concentrations of several COX and ATPase subunits (indicated in the margin) in wild type (W303-1A), Δatp10 and Δcox15mutant cells. The blots were also probed with an antibody
that recognizes porin as a protein loading control. The bars indicate the mean±SD from at least three independent sets of measurements.
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of genetic origin, can destabilize the mtDNA. In our system,
treatment of wild-type yeast cells (W303-1A strain) with 2 μM
oligomycin during 8 h does not affect mtDNA stability (Fig. 2A). In
this time frame, ATPase activity, measured as the ATP hydrolysis
rate, and COX activity decreased both to approximately 35% of wild
type values (Fig. 2B and C). The MRC lesion caused by the inhibition
of the ATPase proton channel is speciﬁc to COX, since the NCCR
activity is not affected in oligomycin treated cells (Fig. 2D). To
further characterize our pharmacological yeast model of ATPase
deﬁciencies, we investigated by western blot analysis the steady
state levels of COX mitochondrial and nuclear encoded subunits.
After 8 h of treatment with 2 μM oligomycin, the steady-state levels
of the three COX core subunits and particularly of Cox1p were
signiﬁcantly decreased compared to the untreated cells (Fig. 2E).
Our results demonstrate that COX biogenesis requires a func-
tional proton pumping ATPase. It was previously shown that COX
assembly and stability also requires the physical presence in the
mitochondrial compartments of the electron carrier cytochrome c
(cyt c), even at sub-stoichiometrical concentrations [6,30]. Cyt c
plays a structural role in COX biogenesis because the sole presence
of an inactive form was sufﬁcient to stabilize COX [6]. To test
whether the effect of ATPase deﬁciency on COX assembly could be
mediated through a severe reduction in cyt c amount, we analyzed
the steady state level of cyt c in oligomycin treated wild type cells
(Fig. 2E) and in the atp10 mutant strain (Fig. 1E). In both cases, cyt c
levels were unaffected indicating that a reduction in cyt c amount is
not part of the mechanism of the pleiotropic COX biogenesis
alteration caused by ATPase deﬁciencies.3.3. Synthesis of Cox1p Is not primarily impaired but down-regulated in
yeast genetic and pharmacological models of ATPase deﬁciency
The prominent decrease in Cox1p steady-state levels raised the
previously proposed possibility that Cox1p synthesis could be
impaired in ATPase defective cells. Cox1p is a key COX subunit
which acts as the seed aroundwhich the enzyme is assembled [48,49].
COX assembly is characterized by a concerted accumulation of its
constitutive subunits. Recently, our group and others have reported
an interesting contribution to the stoichiometric accumulation of
subunits during COX biogenesis in S. cerevisiae. It consists of a
regulatory mechanism by which the Cox1p synthesis is regulated by
the availability of its assembly partners [32,50,51]. The products of
COX14 and MSS51 play a basic role in this Cox1p translational
down-regulation in the absence of COX assembly [32,52]. Mss51p is a
COX1 mRNA speciﬁc translational factor that interacts with the 5′-
untranslated region of the mRNA to promote synthesis [51,52]. It also
interacts with the newly synthesized Cox1p protein possibly to
promote elongation and maturation [32,51] forming a complex that is
stabilized by Cox14p [32] until Mss51p is disengaged from the ternary
complex to participate in new rounds of translation and Cox1p
proceeds in the assembly process [32]. In the absence of COX assembly,
Mss51p is envisioned to remain trapped in the ternary complex and is
not available for Cox1p synthesis. Down-regulation of Cox1p synthesis
in COX assemblymutants can be bypassed at least by twomechanisms.
First, expression of mutant alleles ofmss51 or additional copies of the
wild typeMSS51 gene facilitate COX1mRNA translation in the absence
of COX assembly [32]. Second, the introduction of a cox14 mutation
restores Cox1p synthesis presumably by preventing the trap in the
Fig. 2. The ATPase proton pump inhibitor oligomycin induces a pleiotropic effect on COX accumulation and function in yeast cells. (A) mtDNA stability in wild type cells treated with
2 μMoligomycin. Following the indicated times of incubation, themtDNA stability was estimated by counting the percentage of cells that retained their mtDNA (ρ+ cells). (B) ATPase
activity (C) Cytochrome c oxidase activity (COX) and (D) NADH cytochrome c reductase (NCCR) activity measured as in Fig. 1 in wild type cells incubated in the presence of 2 μM
oligomycin during the indicated times. The bars indicate the mean±SD from at least three independent sets of measurements. ⁎Pb0.001. (E) Western blot analyses of the steady
state concentrations of several COX and ATPase subunits (indicated in the margin) in wild type (W303-1A) cells treated with 2 μM oligomycin. The blots were also probed with an
antibody that recognizes porin as a protein loading control.
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translation. As in bona ﬁde COX assembly mutants, in the atp10
mutant, the rate of Cox1p synthesis is reduced to less than 10% of wild
type (Fig. 3A). Similar to COX mutants, the mitochondrial synthesis
proﬁle in atp10mutant cells also displays the appearance of mp15, an
aberrant COX1 mRNA translation product synthesized in the absence
or limited amounts of translationally competent Mss51p [52]. The
Cox1p synthesis defectwas restored by either deleting COX14 (Fig. 3A)
or by integrating a second copy ofMSS51 into the nuclear genome (the
mss51T167R allele previously shown to restore Cox1p synthesis inmost
COX mutants [32]) (Fig. 3B), two of the hallmarks of the Cox1p
translational regulatory loop previously described [32]. In the double
mutant Δatp10Δcox14 strain, COX activity was null as expected due to
the absence of Cox14p. In Δatp10 cells expressing the mss51T167R
allele, the increase in Cox1p synthesis did not enhance COX assembly
since residual COX activity remained as low as in the Δatp10 cells
(Fig. 3C). Although COX1 mRNA translation was enhanced in these
cells, newly synthesized Cox1p failed to accumulate in the steady-
state, probably as a consequence of fast degradation in the absence of
COX assembly (not shown).
Similarly, in vivo mitochondrial protein synthesis analysis in
oligomycin treated wild type cells showed a reduced rate of Cox1p
synthesis (Fig. 3D). Oligomycin treatment did not affect Cox1p
synthesis in Δcox14 cells (Fig. 3D) in which COX1 mRNA translation
is known to escape translational regulation. Interestingly, and
although not developed here, the rate of synthesis of ATPase
subunits 6, 8 and 9 in atp10 cells and particularly in oligomycin
treated cells, was found signiﬁcantly increased (Fig. 3D and 4D),probably as a compensatory mechanism in the absence of a func-
tional ATPase.
We concluded that the Cox1p synthesis down-regulation is a
consequence rather than a cause of COX assembly defects in atp10
mutants and oligomycin-treated wild type cells.
3.4. ATPase deﬁciency induces membrane hyperpolarization which is
restored to wild-type levels by the ionophore CCCP
The results obtained with the oligomycin inhibited cells suggested
that the proton-pumping ATPase function rather than a structural
ATPase absence and/or alteration would be responsible for the COX-
deﬁcient phenotype observed in these cells. To test whether the
decrease in COX assembly observed in some ATPase mutants is the
result of an increase in mitochondrial Δψm , we have explored the
effect of the uncoupler ionophore carbonyl cyanide m-chloro phenyl
hydrazone (CCCP) on COX biogenesis in the absence of a functional
ATPase. We used concentrations ranging from 1 to 5 μM CCCP which
are known to cause a partial uncoupling of mitochondria and to only
slightly affect the import of precursor proteins in isolated mitochon-
dria [53,54].
As expected, the alterations in the proton pumping ATPase
function induced by both oligomycin and atp10 mutation generated
a mitochondrial membrane hyperpolarization (Fig. 4A) as measured
by ﬂow cytometry using the cationic dye rhodamine 123 (Rh123) as
reported [38]. In the assay conditions, explained in the Experimen-
tal procedures, Rh123 quenching is proportional to mitochondrial
Δψm [39]. The ionophore CCCP partially dissipated the Δψm in wild
Fig. 3. Synthesis of Cox1p is not primarily impaired but down-regulated in yeast genetic and pharmacological models of ATPase deﬁciency. (A) In vivo labeling of mitochondrial gene
products with [35S]methionine at 30 °C for 15 min in the presence of cycloheximide in wild type (W303-1A) and atp10 null mutant cells and the same strains carrying an additional
null mutation in cox14. The numbers 1 and 2 indicate two independent clones. Strains carrying a null mutation in the COX assembly factor cox15 were also included. (B) In vivo
labeling of mitochondrial gene products as in (A) in atp10 null mutant cells expressing or not a second copy of MSS51 consisting of the allele mss51T167R able to bypass the down-
regulation of Cox1p expression in COX assembly mutants. A null mutant of cox15 was also included. (C) COX activity measured spectrophotometrically as in Fig. 1 in atp10 null
mutant cells carrying a second mutation in cox14 or expressing mss51T167R. (D) In vivo labeling of mitochondrial gene products as in (A) in wild type cells and cells carrying a null
allele of cox14 pre-incubated during 8 h. in the presence of 2 μM oligomycin. After labeling, the samples were processed as detailed in Materials and methods. The mitochondrial
translation products are identiﬁed in themargin. In the lower portion of panels (A) and (B), the images were digitalized and densitometry performed using the histogram function of
the Adobe Photoshop program. The ratio of the Cox1p signal versus the signal of Var1, Cox2p and cytochrome b are presented as percentage of the values obtained for the untreated
samples. The values measured in two independent assays did not differ by more than 5%.
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also compensated for the oligomycin- and atp10 mutation-induced
hyperpolarization, restoring wild type Δψm in these strains (Fig.
4A).
3.5. CCCP alleviates the COX biogenesis defect in yeast pharmacological
models of ATPase deﬁciency but not in a Δatp10 mutant
The observation that CCCP restores Δψm in Δatp10 and oligomycin
treated cells suggested that if this parameter were relevant for the
pleiotropic COX assembly defect, CCCP treatment could also restore
COX biogenesis.
Treatment of wild-type yeast cells with 5 μMCCCP alone for 8 h did
not signiﬁcantly affect COX and NCCR activities (Fig. 4B and C).
Interestingly, wild-type cells supplemented with oligomycin together
with CCCP show COX activity levels comparable to the untreated
control value (Fig. 4B). Furthermore, while oligomycin and CCCP do
not produce anymajor direct effect in the rate of in vivomitochondrial
protein synthesis (preincubation time 0 in Fig. 4D), incubation for 8 h
of a wild-type strain with 2 μM oligomycin together with 5 μM CCCPalso restored Cox1p synthesis compared to oligomycin treated cells
(Fig. 4D). These results further support the conclusion that in ATPase-
deﬁcient strains Cox1p synthesis is downregulated as a consequence
of the COX assembly defect.
Contrary to the results obtained in oligomycin treated cells,
incubation of Δatp10 cells with several CCCP concentrations failed
to signiﬁcantly restore COX activity (Fig. 4E). These results suggest
that a fully assembled, structurally integral ATPase is required for COX
assembly.
3.6. CCCP alleviates the COX biogenesis defect in oligomycin-treated
human cultured cells but not in an Atp12-deﬁcient cell line
The dependence of COX biogenesis on a functional ATPase is
conserved from yeast to higher eukaryotes. To validate the results
obtained in yeast models of ATPase deﬁciencies, we developed a
pharmacological human cell culturemodel based on ATPase inhibition
with oligomycin in human neonatal ﬁbroblasts (CCD-10645 k)
obtained from ATCC (Manassas, VA). In these cells, the mtDNA
content remains signiﬁcantly stable after 16 h of exposition to 5 μM
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Fig. 5. The ATPase inhibitor oligomycin induces a pleiotropic speciﬁc effect on COX accumulation and function in human cells that is alleviated in the presence of CCCP. (A)
Mitochondrial DNA content in neonatal ﬁbroblasts (nFIB) incubated during 16 h. in the presence of 5 μM oligomycin, 5 μM CCCP or both was estimated by Southern blot analysis as
the ratio between the signals obtained using a probe against mitochondrial DNA and another against the nuclear encoded 18S rRNA, used to normalize the signals. (B) Cytochrome c
oxidase (COX) and NADH cytochrome c reductase (NCCR) activities measured spectrophotometrically in frozen-thawed cells incubated during 16 h. in the presence of 5 μM
oligomycin, 5 μM CCCP or both. (C) Effect of CCCP on COX activity in cells treated with oligomycin as in panel B and in ATP12-deﬁcient ﬁbroblasts. The bars indicate the mean±SD
from at three independent sets of measurements. ⁎Pb0.001. (D) Western blot analyses of the steady-state levels of COX subunit 1 (COX1) in cells treated with oligomycin, CCCP or
both simultaneously. The blot was also probed with an antibody that recognizes β-tubulin as the loading control.
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activity was speciﬁcally reduced to approximately 45% of control
values (Fig. 5B) as well as the steady state levels of COX subunit 1 (Fig.
5D). The addition of 5 μM CCCP to the oligomycin treated cells
signiﬁcantly restored these parameters (Fig. 5C and D). To validate our
ﬁndings in cells from human patients, we have obtained from Dr. S.
Seneca (University Hospital VUB, Brussels, Belgium) cultured primary
ﬁbroblasts from the single patient described carrying a mutation in
ATP12 [15]. Studies in S. cerevisiae have previously shown that
Atp12p binds to unassembled alpha subunits of the F1 sector thus
preventing its homo-oligomerization in non-productive complexes
during assembly of the F1 moiety of the mitochondrial ATP synthase
[55,56]. We have immortalized the ﬁbroblast cell line by transducing
human papilloma virus (HPV) 16 E6/E7 oncogenes. An initial analysis
using cell homogenates has shown that the ATP12 mutation in these
cells induces a pleiotropic 40% decrease in COX activity in comparison
with human neonatal ﬁbroblasts immortalized in the same way (Fig.
5C). However, similar to yeast Δatp10 cells, COX activity in these cells
was not restored by treatment with CCCP.
Taken together our results obtained in yeast cells and human
ﬁbroblasts indicate that the dependence of COX biogenesis on a
functional ATPase and the mechanisms involved are conserved along
evolution.Fig. 4. CCCP alleviates the COX biogenesis Defect in yeast pharmacological models of ATPase d
estimated by ﬂow cytometry using rhodamine 123 (Rh123). The experiment was perform
proportional to Ψm. (B) Cytochrome c oxidase (COX) and (C) NADH cytochrome c reduct
incubated for 8 h in the presence of oligomycin, CCCP or both. (D) In vivo labeling of mitocho
cycloheximide in wild type (W303-1A) cells pre-incubated (8) or not (0) in the presence
labeling was performed in the presence of the indicated supplements in each case. In the low
function of the Adobe Photoshop program. The ratio of the Cox1p signal versus the signal of V
untreated samples. The values measured in two independent assays did not differ by more th
the presence of the indicated CCCP concentrations. The bars indicate the mean±SD from a4. Discussion
Biogenesis of a functional COX complex is a highly regulated
process. Themultiple levels of regulation described to date involve the
transcriptional and translational control of subunits and assembly
factors accumulation, availability of heme A and copper co-factors,
protein import into mitochondria and membrane insertion, and
coordination of sequential or simultaneous steps of the process
(reviewed in [57]). Additionally, the arrangement and integrity of the
mitochondrial respiratory chain and oxidative phosphorylation
system in the inner mitochondrial membrane plays a crucial role on
COX stability and assembly [30]. Here we report that the F1F0-ATPase
functions in COX biogenesis through a mechanism conserved from
yeast to human that does not involve the synthesis of mitochondrial
DNA encoded COX subunits.
The pleiotropic COXbiogenesis defect observed inmost S. cerevisiae
nuclear mutants that severely affect ATPase assembly and/or function
[16–20] has been suggested to stem from a decrease in synthesis of
Cox1p [18,19,24] or itsmaturation by hemeA insertion [17]. The role of
ATPase on COX assemblywas recently better explored in a S. cerevisiae
strain carrying an atp6 deletion and engineered to stably maintain its
mtDNA under selection [24]. The lack of Atp6p resulted in a selective
decrease in COX accumulation to residual amounts barely detectableeﬁciency but not in aΔatp10mutant. (A) Mitochondrial membrane potential (Ψm)was
ed in Rh123 self-quenching mode as reported [38] and then ﬂuorescence is inversely
ase (NCCR) activities measured spectrophotometrically as in Fig. 1 in wild type cells
ndrial gene products with [35S]methionine at 30 °C for 5 and 10 min in the presence of
of 2 μM oligomycin, 5 μM m-chlorophenylhydrazone (CCCP), or both compounds. The
er panel, the images were digitalized and densitometry performed using the histogram
ar1, Cox2p and cytochrome b are presented as percentage of the values obtained for the
an 5%. (E) COX activity measured in wild type and Δatp10 cells incubated during 8 h in
t least three independent sets of measurements.
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oligomycin-treated andΔatp10mutant cellmodels, inwhichmtDNA is
highly stable, we have examined whether Cox1p translation could be
impaired by the ATPase lesion. We have previously reported that in S.
cerevisiae wild type cells, COX1 mRNA translation is contingent with
the availability of its assembly partners, thereby acting as a negative
feedback loop that paces Cox1p translation to its utilization during
assembly of the complex [32,36,51]. Our results clearly demonstrate
that the apparent reduction in the rate of Cox1p synthesis results from
a down-regulation of Cox1p translation in the absence of COX
assembly through a mechanism involving Mss51p and Cox14p, as
previously described for bona ﬁde COX mutants as well as for cyt c
mutants [32]. Thus, down-regulation of Cox1p synthesis in ATPase-
deﬁcient cells is a consequence rather than a cause of the pleiotropic
COX biogenesis alteration.
To understand the mechanism by which the F1F0-ATPase affects
COX biogenesis and whether it involves functional or structural
constraints, we have used both pharmacological and genetic models
of ATPase deﬁciencies in yeast and cultured human cells. In yeast cells,
oligomycin-inhibition of the ATPase proton pump as well as atp10
deletion induced mitochondrial membrane hyperpolarization. This
effect was reverted by treatment with the ionophore CCCP by limiting
or eliminating the increase in Δψm caused by the absence of a
functional ATPase proton pump. However, CCCP treatment only
restored COX activity in oligomycin treated cells but not in Δatp10
cells defective in F1F0-ATPase assembly. A similar pattern of
restoration was observed in oligomycin-inhibited human cells and
in ﬁbroblasts from a patient carrying a mutation in the F1 alpha
subunit chaperone ATP12, both of which also expressed a pleiotropic
COX deﬁciency. These results suggest that COX biogenesis is impaired
in ATPase-deﬁcient strains at least by two independent mechanisms.
First, it results from an increase in the mitochondrial Δψm in the
absence of a functional proton-pumping ATPase. It remains to be
elucidated the COX assembly step/s that would be primarily affected
by the membrane hyperpolarization caused by ATPase lesions.
Second, the absence of a fully assembled ATPase probably introduced
additional structural constraints for COX biogenesis, discussed
elsewhere [24,28,47], that could not be bypassed solely by restoring
Δψm. Although physical interactions of COX and ATPase have not been
reported in eukaryotic cells, it was recently demonstrated a physical
interaction between the cytochrome caa3 and F1F0-ATP synthase from
Bacillus pseudoﬁrmus OF4 in a reconstituted system [58]. The authors
suggested that such an interaction between these complexes may
contribute to sequestered proton transfer during alkaliphile oxidative
phosphorylation at high pH [58]. Further studies should clarify
whether this interaction occurs in vivo and if similar contacts exist
between eukaryotic COX and ATP synthase.
In addition to its well-established function in ATP generation, the
F1F0-ATP synthase has a role in determining the ultra-structure of
mitochondria [59–61], which depends on its ability to form dimeric
and higher oligomeric super-complexes [59–62]. Initial studies on
mutants of the dimer-speciﬁc subunits e and g, which destabilize
dimeric and oligomeric F1F0-ATP synthase supercomplexes, showed
that they had normal ATPase enzymatic activities, normal mito-
chondrial morphology, and COX activity was affected to a minor
extent (retain ∼80% of wild type COX activity) indicating that
ATPase dimerization and oligomerization are not essential for COX
assembly [29]. In contrast, a more recent study revealed COX activity
was decreased to 55% and 75% of wild type levels in strains missing
subunits e and g, respectively, probably resulting from an altered
organizational state of the super-complex formed by complexes bc1
and COX, which stoichiometry was found altered in the mutant
strains [28]. Studies in S. cerevisiae mutants that are unable to form
the F1 α3β3 oligomer, either because the α or the β subunit is
missing or because the cells are deﬁcient for proteins that mediate
F1 assembly (e.g. Atp11p, Atp12p, or Fmc1p), have pleiotropiceffects predominantly in COX although also, to a lesser extent, on
Complex III or bc1 complex [47]. These mutants were devoid of
mitochondrial cristae, supporting the idea that the F1F0-ATPase is
important for biogenesis of the mitochondrial inner membrane.
Similarly, null mutations in atp6 were reported to signiﬁcantly alter
the mitochondrial ultrastructure and produce a profound COX
biogenesis defect [24]. However, it remained unclear to which
degree and whether or not the COX deﬁciency resulted from the
altered mitochondrial ultra-structure.
In addition to the biological interest, the pleiotropic effects of
ATPase deﬁciencies have a clear biomedical signiﬁcance since
mutations in nuclear and mitochondrial genes affecting ATPase
biogenesis cause devastating encephalomyopathies of childhood [1].
The complex and variable clinical manifestations characteristic of
ATPase deﬁciencies are the result of both the energy deprivation
caused by the primary defect in ATP synthesis and the pleiotropic
effects associated with the ATPase lesions, e.g. decrease in COX
activity and increase in ROS production. Treatments targeting these
pleiotropic effects could be beneﬁcial even without restoring full ATP
production. For example, analysis of the NARP mutation T8,993G in
cybrids cell lines also showed aMRC deﬁciency, including a prominent
COX defect, which interestingly was alleviated by supplementing the
growth media with antioxidants [12].
Using the dye CM-H2-DCFDA (5-(and 6)-chloromethyl-2′7′-
dichloro-dihydroﬂuorescein diacetate acetyl ester) for the detection
of unspeciﬁc ROS, we have measured by ﬂow cytometry a 1.7 fold
increase of ROS in yeast atp10 cells. ROS were efﬁciently chelated by
treatment with the antioxidant N-acetyl-cysteine (10 mM NAC). The
NAC treatment produced an increase in COX activity in both wild type
(from 100% to 120%) and atp10 cells (from 14% to 28%) (Fig. S1).
However, a consistent similar increase was observed in NCCR activity
and in citrate synthase activity (Fig S1), the latter a tricarboxylic acid
cycle enzyme. These results suggest that the antioxidant treatment
could be promoting a general increase in mitochondrial biogenesis,
thus contributing to enhance the residual COX activity in yeast atp10
cells. Incidentally, stimulating mitochondrial biogenesis has proven to
be an effective mechanism to ameliorate partial COX defects in yeast
[41], mammalian cells [63] and mouse models of COX deﬁciency [64].
The further characterization of the pathways involved in the
dependence of COX assembly upon a functional and structurally intact
ATPase could allow for the discovery of new targets for therapeutic
interventions aiming to ameliorate the clinical manifestations in
patients by alleviating this pleiotropic effect that is a signiﬁcant
component of the pathophysiology of ATPase deﬁciency.
In conclusion, functional and structural constraints are responsible
for the pleiotropic COX assembly defect observed in ATPase-deﬁcient
cells. Future work will focus on the discovery of the exact mechanisms
involved and the COX assembly biogenesis steps primarily affected,
which are expected to shed light into new regulatory levels of
mitochondrial membrane biogenesis and organization.
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